| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Departments of Radiology and Medicine, Stanford University School of Medicine Stanford, California
Patients with severe Graves' ophthalmopathy have been treated by selective orbital irradiation using a well-collimated, high-energy, x-ray beam generated by a linear accelerator. Severity of involvement and response to therapy was judged by a numerical scoring procedure and by clinical assessment. Of 23 patients treated, 15 (65%) experienced an excellent or good response, which occurred soon after the start of radiotherapy. No patient was made worse by treatment. A favorable response to orbital irradiation was observed even in some patients who had previously responded poorly to systemic corticosteroid therapy. Severe visual acuity loss or elevated intraocular pressure were not considered to be contraindications to radiation treatment. Severe asymmetrical extra-ocular paresis was not relieved following treatment, even though other concomitant manifestations of ophthalmopathy improved. Anatomic, physiologic and immunologic concepts concerning the pathogenesis of the eye lesions constitute the rationale for the treatment employed. The fundamental pathologic process is thought to represent a cellular immune reaction in extra-ocular muscles.
Supported by Grants AM-07642, CA-05838 and Grant RR70, General Clinical Research Centers, Division of Research Resources; USPHS, National Institutes of Health, Bethesda, Md.
1 Presented in part at the 48th annual meeting of the American Thyroid Association, Chicago, September, 1972.
Received January 18, 1973.
This article has been cited by other articles:
 |
|
 |
|
  H. Stiebel-Kalish, E. Robenshtok, M. Hasanreisoglu, D. Ezrachi, I. Shimon, and L. Leibovici Treatment Modalities for Graves' Ophthalmopathy: Systematic Review and Metaanalysis J. Clin. Endocrinol. Metab., August 1, 2009; 94(8): 2708 - 2716. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P.W. Serruys, G. Sianos, W. van der Giessen, H.J.R.M. Bonnier, P. Urban, W. Wijns, E. Benit, M. Vandormael, R. Dorr, C. Disco, et al. Intracoronary {beta}-radiation to reduce restenosis after balloon angioplasty and stenting. The Beta Radiation In Europe (BRIE) study Eur. Heart J., September 1, 2002; 23(17): 1351 - 1359. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. A McNab, K. P Cockerham, J. S Kennerdell, and M. P. Mourits Does radiotherapy have a role in the management of thyroid orbitopathy? Br J Ophthalmol, January 1, 2002; 86(1): 102 - 107. [Full Text] [PDF]
|
|
|
|
|
|
M. Kazim, S. L Trokel, G. Acaroglu, and A. Elliott Reversal of dysthyroid optic neuropathy following orbital fat decompression Br J Ophthalmol, June 1, 2000; 84(6): 600 - 605. [Abstract] [Full Text]
|
|
|
|
 |
|
 L. Bartalena, A. Pinchera, and C. Marcocci Management of Graves' Ophthalmopathy: Reality and Perspectives Endocr. Rev., April 1, 2000; 21(2): 168 - 199. [Abstract] [Full Text]
|
|
|
|
 |
|
 D. P Lee, S. Lo, K. Forster, A. C Yeung, and S. N Oesterle Clinical applications of brachytherapy for the prevention of restenosis Vascular Medicine, November 1, 1999; 4(4): 257 - 268. [Abstract] [PDF]
|
|
|
|
 |
|
 S. B. King, D. O. Williams, P. Chougule, J. L. Klein, R. Waksman, R. Hilstead, J. Macdonald, K. Anderberg, and I. R. Crocker Endovascular ß-Radiation to Reduce Restenosis After Coronary Balloon Angioplasty : Results of the Beta Energy Restenosis Trial (BERT) Circulation, May 26, 1998; 97(20): 2025 - 2030. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. B. Wilson and M. Prochoda Radiotherapy for Thyroid Orbitopathy: Effects on Extraocular Muscle Balance Arch Ophthalmol, November 1, 1995; 113(11): 1420 - 1425. [Abstract] [PDF]
|
|
|
|
|
|
S. C. S. Kao, D. L. Kendler, R. A. Nugent, J. S. Adler, and J. Rootman Radiotherapy in the Management of Thyroid Orbitopathy: Computed Tomography and Clinical Outcomes Arch Ophthalmol, June 1, 1993; 111(6): 819 - 823. [Abstract] [PDF]
|
|
|
|
 |
|
 D. A. Girod, J. C. Orcutt, and C. W. Cummings Orbital Decompression for Preservation of Vision in Graves' Ophthalmopathy Arch Otolaryngol Head Neck Surg, February 1, 1993; 119(2): 229 - 233. [Abstract] [PDF]
|
|
|
|
 |
|
 T. W. H. KAY, P. HEYMA, L. C. HARRISON, and F. I. R. MARTIN Graves Disease Induced by Radioactive Iodine Ann Intern Med, December 1, 1987; 107(6): 857 - 858. [Abstract] [PDF]
|
|
|
|
 |
|
 P. R. Gliedman and A. D. Steinfeld Radiation Retinopathy JAMA, February 13, 1987; 257(6): 780 - 780. [Abstract] [PDF]
|
|
|
|
|
|
J. S. Glaser Graves' Ophthalmopathy-Reply Arch Ophthalmol, August 1, 1985; 103(8): 1110 - 1112. [Abstract] [PDF]
|
|
|
|
|
|
J. L. Kinyoun, R. E. Kalina, S. A. Brower, R. P. Mills, and R. H. Johnson Radiation Retinopathy After Orbital Irradiation for Graves' Ophthalmopathy Arch Ophthalmol, October 1, 1984; 102(10): 1473 - 1476. [Abstract] [PDF]
|
|
|
|
 |
|
 R. E. Appen, D. Wendelborn, and W. E. Nolten Diplopia in Autoimmune Thyroid Disease Arch Intern Med, May 1, 1982; 142(5): 898 - 901. [Abstract] [PDF]
|
|
|
|
|
|
J. S. Kennerdell, A. E. Rosenbaum, and M. H. El-Hoshy Apical Optic Nerve Compression of Dysthyroid Optic Neuropathy on Computed Tomography Arch Ophthalmol, May 1, 1981; 99(5): 807 - 809. [Abstract] [PDF]
|
|
|
|
|
|
R. C. Sergott, J. S. Glaser, and K. Charyulu Radiotherapy for Idiopathic Inflammatory Orbital Pseudotumor: Indications and Results Arch Ophthalmol, May 1, 1981; 99(5): 853 - 856. [Abstract] [PDF]
|
|
|
|
|
|
S. T. BIGOS, B. C. NISULA, G. H. DANIELS, R. C. EASTMAN, H. H. JOHNSTON, and P. O. KOHLER Cyclophosphamide in the Management of Advanced Graves' Ophthalmopathy: A Preliminary Report Ann Intern Med, June 1, 1979; 90(6): 921 - 923. [Abstract] [PDF]
|
|
|
|
|
|
J. D. Trobe, J. S. Glaser, and P. Laflamme Dysthyroid Optic Neuropathy: Clinical Profile and Rationale for Management Arch Ophthalmol, July 1, 1978; 96(7): 1199 - 1209. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
